Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11

Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11

NPR

Published

The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.

Full Article